Share this article
Share this article
CHICAGO, April 20, 2021 /PRNewswire/ Innovative tech company Kalderos today released its 2021 annual report. The report highlights the company s perspective on key challenges in the drug channel, leverages unique data to provide insights into drug discount programs, and advocates for a new model that utilizes platform technology to make drugs more affordable for patients. As we dive deeper into 2021, we see big developments on the horizon for the business of healthcare, said Kalderos CEO Jeremy Docken. Industry trends are driving change and so is the massive impact of COVID-19. A new administration is tackling drug pricing. During this pivotal moment, it s the perfect time to launch our inaugural annual report.
Kalderos upgrades 340B Pay platform, giving covered entities more options
Kalderos 340B Pay, a first-of-its-kind platform solution for Drug Discount Management, now gives providers the flexibility to use a rebate or discount model
News provided by
Share this article
Share this article
CHICAGO, Dec. 15, 2020 /PRNewswire/ Drug Discount Management company Kalderos today announced a significant upgrade to its 340B Pay solution that gives covered entities more choice in how they realize the benefits of the 340B program. Covered entities will now be able to choose whether to use the rebate model for their own pharmacies, or maintain their existing process of upfront discount and wholesaler chargeback.